Dominic Tisi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Dominic Tisi

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|January 16, 2009

Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activitySteven Howard, Valerio Berdini, John A Boulstridge, et al.

ACS Medicinal Chemistry Letters|October 20, 2022

Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 InhibitorEmiliano Tamanini, Shin Miyamura, Ildiko M Buck, et al.

Journal of Medicinal Chemistry|June 27, 2024

Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β-GlucocerebrosidaseNick Palmer, Christopher Agnew, Caroline Benn, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|January 16, 2009

Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activitySteven Howard, Valerio Berdini, John A Boulstridge, et al.

ACS Medicinal Chemistry Letters|October 20, 2022

Fragment-Based Discovery of a Novel, Brain Penetrant, Orally Active HDAC2 InhibitorEmiliano Tamanini, Shin Miyamura, Ildiko M Buck, et al.

Journal of Medicinal Chemistry|June 27, 2024

Fragment-Based Discovery of a Series of Allosteric-Binding Site Modulators of β-GlucocerebrosidaseNick Palmer, Christopher Agnew, Caroline Benn, et al.

Pageof 2